BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/15/2026 8:38:36 AM | Browse: 3 | Download: 0
 |
Received |
|
2025-05-12 02:32 |
 |
Peer-Review Started |
|
2025-05-13 08:49 |
 |
First Decision by Editorial Office Director |
|
2025-06-07 02:19 |
 |
Return for Revision |
|
2025-06-07 02:19 |
 |
Revised |
|
2025-06-20 11:04 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-03-27 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-03-27 07:28 |
 |
Articles in Press |
|
2026-03-27 07:28 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2026-05-28 08:19 |
 |
Publish the Manuscript Online |
|
2026-06-15 08:38 |
| ISSN |
2220-6124 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
Fabry disease is a rare genetic disorder with variable clinical expression, often underdiagnosed in developing countries. Renal involvement, although frequent and prognostically significant, may be subtle or misattributed to more common nephropathies. This report of six related cases highlights the diagnostic challenges in recognizing Fabry nephropathy, particularly where access to genetic testing and renal biopsy is limited. Early identification through family screening and targeted evaluation is crucial to improve renal outcomes, especially in low-resource settings. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Case Report |
| Article Title |
Renal involvement in Fabry disease from Tunisian families: Six case reports
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Syrine Tlili, Hiba Ghabi, Ikram Mami, Fethi Ben Hmida, Lamia Rais and Mohamed Karim Zouaghi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Syrine Tlili, Associate Professor, Department of Nephrology, Dialysis and Transplantation, La Rabta Hospital, Street Jebberi, Tunis 1007, Tunisia. syrine.tlili@fmt.utm.tn |
| Key Words |
Fabry disease; Chronic kidney disease; Genetic disorder; X-linked disorder; Case report |
| Core Tip |
Fabry disease is a rare genetic disorder with variable clinical expression, often underdiagnosed in developing countries. Renal involvement, although frequent and prognostically significant, may be subtle or misattributed to more common nephropathies. This report of six related cases highlights the diagnostic challenges in recognizing Fabry nephropathy, particularly where access to genetic testing and renal biopsy is limited. Early identification through family screening and targeted evaluation is crucial to improve renal outcomes, especially in low-resource settings. |
| Publish Date |
2026-06-15 08:38 |
| Citation |
Tlili S, Ghabi H, Mami I, Ben Hmida F, Rais L, Zouaghi MK. Renal involvement in Fabry disease from Tunisian families: Six case reports. World J Nephrol 2026; 15(2): 109420
|
| URL |
https://www.wjgnet.com/2220-6124/full/v15/i2/109420.htm |
| DOI |
https://doi.org/10.5527/wjn.v15.i2.109420 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.